Dominican Republic vs Lithuania: Treatment success rate for patients treated for MDR-TB
Dominican Republic
70.0%
in 2022
Lithuania
70.0%
in 2022
Dominican Republic rank
96th
Lithuania rank
96th
Treatment success rate for patients treated for MDR-TB over time
- Dominican Republic
- Lithuania
How they compare
Dominican Republic currently reports 70.0% against 70.0% in Lithuania, a difference of 0.0%.
The two have swapped places 3 times across 16 shared years of data; in 2007 it was Dominican Republic ahead.
Dominican Republic ranks 96th and Lithuania ranks 96th of 163 countries.
Dominican Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.0% | 19.7% | 45.3% | Dominican Republic |
| 2010s | 61.9% | 47.7% | 14.2% | Dominican Republic |
| 2020s | 71.0% | 68.3% | 2.7% | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Dominican Republic or Lithuania?
- Dominican Republic, at 70.0% against 70.0% in Lithuania as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Dominican Republic and Lithuania?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Lithuania?
- 16 years are reported by both, from 2007 to 2022.
- How do Dominican Republic and Lithuania rank globally for treatment success rate for patients treated for mdr-tb?
- Dominican Republic ranks 96th and Lithuania ranks 96th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.